A Phase 2 Study of CRD-4730 in CPVT

Clinical trial NCT06658899 · RECRUITING

Trial details

NCT number: NCT06658899
Sponsor: Cardurion Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Catecholaminergic Polymorphic Ventricular Tachycardia

Start date: 2025-12-01
Primary completion: 2027-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.